Pharmaceutical composition for use in preventing or treating osteoporosis containing eucalyptol as an active ingredient

摘要

The present invention relates to a pharmaceutical composition comprising eucalyptol or a pharmaceutically acceptable derivative thereof as an active ingredient. The pharmaceutical composition according to the present invention is characterized in that the osteoblast differentiation marker genes Id1, Dlx5, Runx2, ALP, OC And the osteoblast differentiation is promoted by increasing the expression level of osteoblast and increasing the calcification of osteoblast. Thus, it can be widely used as a medicine or a health food for the prevention or treatment of osteoporosis. In addition, rather than targeting osteoclasts, osteoblast activity can be increased to promote osteogenesis, thereby osteoporosis can be fundamentally treated, and secondary osteoporosis can be effectively prevented.